Literature DB >> 25113585

Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.

Sheron Boswell Thompson, Cerese Hepburn Brown, Ann Marie Edwards, Jascinth L M Lindo.   

Abstract

OBJECTIVES: To determine the level of adherence and possible barriers to secondary prophylaxis among clients with rheumatic fever in Kingston, Jamaica.
METHODS: Cross-sectional survey of 39 clients diagnosed with rheumatic fever, receiving penicillin prophylaxis for more than a year using a 22-item self-administered questionnaire on adherence to secondary prophylaxis and knowledge of rheumatic fever. The patients' records were reviewed to determine the number of prophylaxis injections the patients received for the year 2010.
RESULTS: The majority of participants (74%) were females and 51% were adults. Only 48·7% had a high level of adherence. The majority (72%) had low knowledge levels regarding their illness, while only 5% had a high knowledge level score. Most clients (70%) strongly agreed that nurses and doctors encouraged them to take their prophylaxis. However, over 60% reported that they travelled long distances and or waited long periods to get their injections. One-third reported that they missed appointments because of fear of injections and having to take time off from work or school. DISCUSSION: Clients attending the health centers studied had limited knowledge about rheumatic fever. Barriers to adherence included fear of the injections, long commutes, and long waiting periods at the facilities studied.

Entities:  

Keywords:  Adherence,; Barriers,; Jamaica; Rheumatic fever,; Secondary Prophylaxis,

Mesh:

Substances:

Year:  2014        PMID: 25113585      PMCID: PMC4153824          DOI: 10.1179/2047773214Y.0000000146

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  19 in total

1.  Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions.

Authors:  D Berry; A Bradlow; E Bersellini
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

2.  Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component.

Authors:  S Kiortsis; K Kachrimanis; Th Broussali; S Malamataris
Journal:  Eur J Pharm Biopharm       Date:  2005-01       Impact factor: 5.571

3.  Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.

Authors:  Sabry Eissa; Rosemary Lee; Philippa Binns; Gaynor Garstone; Malcolm McDonald
Journal:  Aust N Z J Public Health       Date:  2005-12       Impact factor: 2.939

4.  An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme.

Authors:  Sarah Grayson; Margaret Horsburgh; Diana Lennon
Journal:  N Z Med J       Date:  2006-10-23

Review 5.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

6.  Lack of adherence to the national guidelines on the prevention of rheumatic fever.

Authors:  Katharine A Robertson; Jimmy A Volmink; Bongani M Mayosi
Journal:  S Afr Med J       Date:  2005-01

7.  Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community.

Authors:  Zinta Harrington; David P Thomas; Bart J Currie; Joy Bulkanhawuy
Journal:  Med J Aust       Date:  2006-05-15       Impact factor: 7.738

8.  Lidocaine as a diluent for administration of benzathine penicillin G.

Authors:  J Amir; S Ginat; Y H Cohen; T E Marcus; N Keller; I Varsano
Journal:  Pediatr Infect Dis J       Date:  1998-10       Impact factor: 2.129

9.  Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs.

Authors:  P N Trewby; A V Reddy; C S Trewby; V J Ashton; G Brennan; J Inglis
Journal:  Clin Med (Lond)       Date:  2002 Nov-Dec       Impact factor: 2.659

10.  Confirmed penicillin allergy among patients receiving benzathine penicillin prophylaxis for acute rheumatic fever.

Authors:  A Kaya; M Erkoçoğlu; O G Senkon; F K Ekici; M Toyran; I İ Çetin; C N Kocabaş
Journal:  Allergol Immunopathol (Madr)       Date:  2013-04-08       Impact factor: 1.667

View more
  6 in total

1.  Rheumatic Heart Disease Patients' Adherence to Secondary Prophylaxis and Associated Factors at Hospitals in Jimma Zone, Southwest Ethiopia: A Multicenter Study.

Authors:  Alinur Adem; Tadesse Dukessa Gemechu; Habtemu Jarso; Wondu Reta
Journal:  Patient Prefer Adherence       Date:  2020-12-04       Impact factor: 2.711

2.  Adherence to Benzathine Penicillin G Secondary Prophylaxis and Its Determinants in Patients with Rheumatic Heart Disease at a Cardiac Center of an Ethiopian Tertiary Care Teaching Hospital.

Authors:  Kajela Kibirat Mekonen; Malede Berihun Yismaw; Alfoalem Araba Abiye; Tamrat Assefa Tadesse
Journal:  Patient Prefer Adherence       Date:  2020-02-19       Impact factor: 2.711

3.  Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.

Authors:  Hilary Barker; John G Oetzel; Nina Scott; Michelle Morley; Polly E Atatoa Carr; Keri Bolton Oetzel
Journal:  Int J Equity Health       Date:  2017-11-17

4.  Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: A cross-sectional study in low-income province of India.

Authors:  Arun Prasad; Abhiranjan Prasad; Birendra K Singh; Sanjeev Kumar
Journal:  J Family Med Prim Care       Date:  2020-03-26

5.  Prevalence and risk factors for Subclinical Rheumatic Heart Disease among primary school children in Dar es Salaam, Tanzania: a community based cross-sectional study.

Authors:  Parvina Titus Kazahura; Theophylly L Mushi; Pedro Pallangyo; Mohamed Janabi; Rodrick Kisenge; Mazen Albaghdadi; Naizihijwa Majani; Edward Kija
Journal:  BMC Cardiovasc Disord       Date:  2021-12-20       Impact factor: 2.298

6.  Awareness of rheumatic fever and rheumatic heart disease among the population in taif, Saudi Arabia 2020.

Authors:  Mohammed M Mougrabi; Raghad Sami Aljuaid; Aeshah Dakhel Alrabie; Nouran Khalid Althumali; Lama Humaied Alkhaldi; Waad Dhaifallah Alotaibi
Journal:  J Family Med Prim Care       Date:  2021-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.